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ORIGINAL RESEARCH ARTICLE
Continuous tracking of startled Drosophila as an alternative to the negative
geotaxis climbing assay
Matthew J. Taylor and Richard I. Tuxworth
Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
ABSTRACT
The fruit fly, Drosophila, is commonly used to study late-onset neurodegenerative diseases due to the
combination of powerful genetic tools, cheap and simple husbandry and short lifespan. One widely-
used measure of disease progression is the age-dependent decline in motor performance that mani-
fests in most Drosophila neurodegeneration models. This is usually quantified using a simple climbing
assay. However, the standard climbing assay lacks sensitivity and suffers from high variability meaning
large numbers of flies are needed or bespoke apparatus and software solutions. Here, we present a
modification of the open-source, MATLAB-based, DART software to measure the decline in “startle
response” with age. We demonstrate that the DART setup is more sensitive to the motor performance
decline induced by adult-onset neuronal expression of amyloid beta (Ab) peptides than a traditional
climbing assay despite using smaller cohorts of flies. DART also has the potential to generate multiple
metrics of motor behaviour during the startle response. The software requires no coding skills to oper-
ate and the required apparatus can be purchased commercially. Therefore, DART is a more useful
method than the climbing assay for longitudinal assays of motor performance and will enable higher-
throughput screen for genetic and pharmacological modifiers of neurodegeneration. In our proof-of-
concept screen for modifiers of Ab-dependent phenotypes, we identified that in vivo knock-down of
p53 in adult neurons is neuroprotective. This supports recent work targeting p53 in vitro and demon-
strates the potential for DART to be used to screen for targets that ameliorate neurodegeneration.
ARTICLE HISTORY
Received 29 March 2019
Accepted 17 June 2019
KEYWORDS
Drosophila; climbing assay;
negative geotaxis; DART;
DNA damage response; p53
Introduction
The short lifespan of Drosophila coupled with powerful tools
for genetic manipulation and genome-wide screening com-
bines to make it an attractive model system to study aspects
of human neurodegenerative disorders. Drosophila models
have been particularly widely used for types of dementia,
including Alzheimer’s disease and frontotemporal dementia,
and for various movement disorders, including Parkinson’s
disease and amyotrophic lateral sclerosis (reviewed in:
Bouleau & Tricoire, 2015; Casci & Pandey, 2015; Hewitt &
Whitworth, 2017; McGurk, Berson, & Bonini, 2015). In
many studies, the progressive decline in neural output asso-
ciated with the disease needs to be measured. While neuro-
degenerative disease-relevant phenotypes such as tests of
memory (Saitoe, Horiuchi, Tamura, & Ito, 2011) or changes
to circadian behaviour (Rosato & Kyriacou, 2006) can be
quantified using flies, these assays are complex and ill-suited
to large-scale screens. Consequently, the progressive decline
in motor function is very commonly used as a measure of
neural output. Expression of most of the aggregative pro-
teins associated with human neurodegenerative diseases in
the Drosophila CNS, including amyloid beta (Ab) (Beharry,
Alaniz, & Alonso, 2013), Tau (Kerr et al., 2011), TDP-43
(Voigt et al., 2010, p. 43), or expanded Htt (Romero et al.,
2008), results in an accelerated decline in motor function
with age. Where tested, this correlates with a decline in the
efficiency of neural transmission (Kerr et al., 2011).
The method most commonly used for measuring motor
output takes advantage of the innate negative geotaxis
response displayed by Drosophila when startled. When
tapped to the bottom of a vial, adult flies will climb back
upwards towards the top. This escape reflex has been used
for more than 3 decades by Drosophila researchers
(Ganetzky & Flanagan, 1978) and is the basis of the Rapid
Iterative Negative Geotaxis (RING) assay (Gargano, Martin,
Bhandari, & Grotewiel, 2005) (more commonly referred to
as the climbing assay). In this assay, groups of flies are
transferred into empty vials that are then tapped so that the
flies fall down to the base. The flies climbing back up the
sides of the vial are recorded by camera and the number
reaching a set distance above the base within a time limit is
noted to generate a simple percentage. Alternatively, a per-
formance index is calculated.
The climbing assay, as performed in most laboratories, is
simple to perform but has some significant disadvantages.
The assay requires relatively large numbers of flies –
CONTACT Richard I. Tuxworth r.i.tuxworth@bham.ac.uk Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of
Birmingham, Birmingham B15 2TT, United Kingdom
Supplemental data for this article is available online at https://doi.org/10.1080/01677063.2019.1634065.
 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
JOURNAL OF NEUROGENETICS
https://doi.org/10.1080/01677063.2019.1634065
commonly 100 flies are used per genotype or treatment –
and there is considerable performance variability between
vials of identical flies. There are several possible reasons for
the variability, but variations in the “tapping” force applied
to the vials and the binary scoring system are likely to be
two of the more important. The assay also requires signifi-
cant “hands-on” time, particularly if manual scoring is
employed, and the simple scoring method also misses more
nuanced behavioural metrics, especially the speed of move-
ment. Various solutions to streamline the climbing assay
and improve its reproducibility have been described
(Kohlhoff et al., 2011; Liu et al., 2015; Podratz et al., 2013;
Willenbrink et al., 2016). Each of these requires bespoke
apparatus and software to track the movement of flies and
are not designed for tracking movement over extended peri-
ods with the possibility of differential stimulation events
during that period.
Here, we present an alternative method for monitoring
the locomotor performance of Drosophila over time that
addresses many of the issues with the climbing assay. We
have adapted the MATLAB-based, open-source Drosophila
ARousal Tracking (DART) system (Faville, Kottler, Goodhill,
Shaw, & van Swinderen, 2015) – initially developed to study
long-term circadian behaviour – to continuously monitor
the horizontal movement of flies before, during and after a
startle response. We have used the DART software suite to
apply vibrational stimulus events multiple times over a 1 h
period to elicit repeated “startle” reflexes in the flies. Both
the baseline movement of flies and the increase in move-
ment immediately after the stimulus can be quantified. Here,
we have used an adult-onset Drosophila Alzheimer’s disease
model in which aggregative Ab 1–42 peptides are secreted
from neurons (Speretta et al., 2012) to demonstrate the
improved performance of the DART system in comparison
to the climbing assay. We also highlight how the DART sys-
tem can be used to test compounds or in genetic screens to
identify modifiers of the Ab-induced phenotypes.
Results
Setup of the DART system
Our use of the DART system setup was a slight modification
from its original use for monitoring circadian behaviour
(Faville et al., 2015). The setup is described fully in the
methods but, briefly, flies are housed individually in
Trikinetics activity vials. Prior to the assay, each vial is
clamped horizontally to a platform in cohorts of 20.
Movement is recorded from above both before, during and
after the stimulation events in which the DART software
delivers a train of short vibrational stimuli to small motors
glued to the underside of each platform. Pilot experiments
enabled us to settle on an experimental assay paradigm in
which 4 groups of 20 flies were stimulated 5 times per assay.
The stimulus comprised 5 0.5 s bursts of vibration over 3 s
with each stimulus event separated by 10min, a period long
enough for fly movement to return to the baseline pre-
stimulus speed. Post-recording, the DART software tracks
the positions of each fly throughout the 1 h recording and
quantifies non-stimulated movement and the response of the
population to each of 5 stimulation events. An example of
the paradigm with representative startle responses is shown
in Supplementary Figure 2.
Drosophila Alzheimer’s model
To compare the DART system with the conventional climb-
ing assay, we expressed a dimer of the human amyloid beta
1–42 peptide separated by a flexible 12-amino acid linker
(tAb1–42) (Speretta et al., 2012). The linker facilitates oligo-
merisation and increases toxicity and a N-terminal secretion
motif ensures extracellular aggregation (Speretta et al.,
2012). We expressed tAb1–42 only in adult neurons through
use of the standard Elav-Gal4C155 driver combined with the
temperature-sensitive Gal80ts inhibitor. Flies were reared at
low temperature to prevent expression of tAb1–42 and avoid
confounding effects on neurodevelopment then shifted to
higher temperatures once eclosed as adults.
Comparison of the climbing assay with DART tracking
Initially, we used a standard climbing assay to confirm that
expression of tAb1–42 only in adult neurons would produce
an accelerated decline in motor performance. Flies were
tested in cohorts of 20 and allowed to climb for 10 s after
tapping to the base of the vial. A performance index was cal-
culated using a binary cut-off for climbing success 3 cm
above the base (see “Methods”). As expected, adult flies
shifted to 29 C to maximise expression of tAb1–42 displayed
a very rapid decline in climbing ability and were essentially
unable to climb above the 3 cm line after 10 days (Figure
1(a)); control flies performed significantly better. Flies reared
at 25 C to reduce expression of tAb1–42 maintained their
climbing ability for significantly longer (Figure 1(a)).
Interestingly, the control flies also performed substantially
better when reared at 25 C compared to controls reared at
29 C (Figure 1(a)). This is potentially due to toxicity caused
by expressing large quantities of GAL4 in neurons (Kramer
& Staveley, 2003, p. 4; Rezaval, Werbajh, & Ceriani, 2007)
together with the effects of more rapid ageing when flies are
reared at higher temperatures (Miquel, Lundgren, Bensch, &
Atlan, 1976). However, we did not detect a significant differ-
ence in the gradient of the decline between the control and
tAb1–42 lines at 25 C.
We used the DART system to quantify the startle
response in genetically identical flies reared simultaneously
with those used for climbing assays. We plotted the startle
response as a performance index (see “Methods”) and saw
an age-dependent decline in response (Figure 1(b)). The
day-to-day responses were more variable than for the climb-
ing assay but showed the same pattern of responses at 29 C:
flies expressing tAb1–42 performed significantly worse than
control flies; and control flies raised at 29 C performed sig-
nificantly worse than control flies raised at 25 C. However,
using DART, we were also able to see a significant difference
in the gradient of decline between the control and tAb1–42
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flies at 25 C, which suggests that DART is more sensitive to
subtle differences in phenotype than climbing assays.
Given the extreme toxicity of tAb1–42 at 29 C, we used
data from the flies reared at 25 C and asked whether the
DART system was capable of extracting further movement
information that might give further insight into the behav-
iour of the flies. We compared tAb1–42-expressing and con-
trol flies at 0- and 19- days post-temperature shift to
simulate a 2-point method that might be used in a simple
genetic screen. On day 19, we can detect a significant
decrease in the performance index of the tAb1–42-expressing
flies compared to the control. However, there is no differ-
ence in the mean walking speed between the groups (Figure
1(c)). This suggests a difference in response to a stimulus
without there being a change to baseline locomotor activity.
A difference such as this might not be observed using other
systems, such as the Hillary Climber (Willenbrink et al.,
2016), which rely on measuring the mean speed of flies.
Therefore, DART has the potential to quantify different fac-
ets of motor behaviour during the startle response that are
differentially affected by tAb1–42-expression.
Consistency of the DART tracking system
To be useful as a screening platform, we needed to ensure
that the DART system produces reproducible data across
multiple experiments. We used a breeding paradigm to look
at the effect of Ab expression on the mature adult CNS after
the critical period of neuronal plasticity had ended (Sachse
et al., 2007; Sugie, Marchetti, & Tavosanis, 2018) and com-
pared the performance of the tAb1–42-expressing flies across
4 independent experiments. Adult flies were reared at 18 C
for 1–2 weeks after eclosion and tracked 2–3 times to get a
baseline measurement during this period. Then, the flies
Figure 1. The DART tracking system is more sensitive than the climbing assay. The decline in motor performance of control (w1118) and tAb1–42-expressing flies
quantified using (A) climbing assays and (B) the DART tracking and stimulation system. (A) Motor performance declines significantly more quickly in tAb1–42
expressing flies compared to controls when reared at 29 C post eclosion (p> .0001) but not at 25 C (p¼ .074). (B) Using DART, significant differences can be
detected in both 25 C (p> .0001) and 29 C (p¼ .0035) groups. All comparisons by one-way ANOVA with Tukey’s multiple comparisons test. (C) Whilst there is a
difference in PI (i.e. startle response) at day 19 (p¼ .0121), there is no difference in mean walking speed (p¼ .9898, both two-way ANOVA with Sidak’s multiple
comparisons test). p< .01; p< .0001.
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were shifted to 27 C to induce expression of tAb1–42. As
expected, at 27 C Ab toxicity is intermediate to the 25 and
29 C phenotypes. We found that the slopes of the decline
in motor performance were almost identical across all 4
experiments (Figure 2(a)), indicating that motor perform-
ance can be quantified reproducibly by the DART setup.
Using DART as a screening tool: candidate
neuroprotective compounds
The consistency, reproducibility and speed at which data are
acquired using DART suggests that the system could be
used as part of a higher-throughput screen for pharmaco-
logical or genetic modifiers of the neurodegenerative pheno-
type than would be possible with climbing assays. We tested
this idea initially with Congo Red, a diazo dye that has the
ability to bind to Ab monomers and inhibit fibril formation
(Lorenzo & Yankner, 1994). It has previously been shown
that feeding a Drosophila Ab model Congo Red-enriched
food reduces plaque formation and increases lifespan
(Crowther et al., 2005). However, the authors in that study
were unable to test whether motor performance was rescued
because control flies raised on Congo Red-enriched food
also displayed a significant motor deficit (Crowther et al.,
2005). Since our assay does not rely on climbing ability and
is able to detect more subtle differences in performance
between groups, we used to DART to ask whether Congo
Red can rescue the motor performance of the tAb1–42 flies.
We found that while Congo Red does not have a negative
effect on control flies, it also cannot rescue the motor per-
formance decline of our tAb1–42 model (Figure 2(b)).
Using DART as a screening tool: RNAi screen
Next, we postulated that DART has potential as a genetic
screening tool. As part of a wider project investigating the
role of the DNA damage response (DDR) in mediating Ab
toxicity, we expressed UAS-RNAi to various components of
the DDR alongside tAb1–42. As before, Gal80
ts was used to
restrict expression of tAb1–42 to adult neurons and after the
critical period for plasticity. This also prevented the UAS-
RNAi construct from being expressed and ensured no
knockdown of the target gene expression during develop-
ment or early adulthood.
A RNAi screen must be able to distinguish true positives
from potential effects of expressing the RNAi construct
alone. Expression of the UAS-RNAi alone should lead to
one of three outcomes: no effect; enhancement of the start-
ing phenotype by the RNAi; or suppression (or reversal) of
the starting phenotype by the RNAi. We searched for each
of these outcomes in our pilot screen. First, we tested spn-A
(the homolog of Rad51), which is involved in homologous
recombination (HR), where it binds to processed double-
strand breaks (DSBs) (Sung & Klein, 2006). We observed
that knockdown of spn-A in neurons has no effect on the
decline in motor performance in control or tAb1–42 flies
(Figure 3(a)). Importantly, these data show that simply add-
ing an additional UAS-transgene does not affect Ab toxicity
by diluting out the Gal4.
Figure 2. Utilization of the DART setup for compound screening. (A) Comparison of the performance of the tAb1–42-expressing flies across 4 biological repeats of
the same longitudinal experiment. No significant differences between the slopes were found (p¼ .3396). (B) Feeding flies Congo Red shows no significant improve-
ment in motor performance of control or tAb1–42-expressing flies (p¼ .978 and p¼ .9709 respectively). All comparisons by one-way ANOVA with Tukey’s multiple
comparisons test p< .05.
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Bre1 is involved in the recruitment of Rad6 (Wood et al.,
2003, p. 1), which is required for post-replication repair
through ubiquitination of PCNA (Hoege, Pfander,
Moldovan, Pyrowolakis, & Jentsch, 2002). Knockdown of
Bre1 had no effect on the motor performance decline of our
tAb1–42 model but expression of UAS-Bre1 RNAi alone was
sufficient to produce a decline in motor performance com-
parable to tAb1–42-expression alone (Figure 3(b)).
Both spn-A and Bre1 function in HR, which operates pri-
marily in M- and S-phases of the cell cycle. Given post-
mitotic neurons are in G0, HR is not likely to be a major
mechanism of repair of DSB in adult neurons. Instead,
repair is likely to be via non-homologous end joining
(NHEJ), which does not require a homologous template for
repair (Beucher et al., 2009). Next, we targeted Ku80, a com-
ponent of the heterodimeric Ku complex (with Ku70) which
Figure 3. RNAi screen of DNA damage response components using DART to identify neuroprotective targets. UAS-RNAi to spn-A (A), Bre-1 (B), Ku80 (C) and p53 (D)
was expressed in adult neurons alone or alongside tAb1–42. (A) Knockdown of spn-A in neurons has no effect on the motor performance of control (p¼ .978) or
tAb1–42 flies (p¼ .872). (B) Knockdown of Bre-1 has no effect on the motor performance of tAb1–42 flies (p¼ .878) but Bre-1 RNAi/þ flies perform significantly worse
than controls (p¼ .0099). (C) Knockdown of Ku80 significantly attenuates the motor performance decline of the tAb1–42 flies (p< .0001) but expression of the RNAi
alone increases motor performance compared to control flies (p> .0001).(D) Neural-specific knockdown of p53 significantly attenuates the decline of the tAb1–42
group (p¼ .0088). There is no significant difference between control and p53-RNAi groups (p¼ .5425). All comparisons by one-way ANOVA with Tukey’s multiple
comparisons test. p<.05; p<.01; p<.0001
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threads onto the DNA at the site of the DSB in the first step
of NHEJ (Pannunzio, Watanabe, & Lieber, 2018).
Knockdown of Ku80 in neurons significantly attenuated the
decline in motor performance of Ab- expressing flies.
However, expression of UAS-Ku80 RNAi alone dramatically
increased the response of the control flies to the vibrational
stimuli over time (Figure 3(c)). We eliminated each of these
genes fromconsideration and concluded that our screening
platform would be capable of identifying RNAi constructs
truly suppressing the decline in Ab-induced decline in
motor performance.
Finally, we looked at the effects of knockdown of p53 in
neurons. In response to DSBs, p53 is activated by ATM and
mediates cell-cycle arrest or apoptosis (Amaral, Xavier,
Steer, & Rodrigues, 2010). p53 is upregulated in a number
of neurodegenerative disorders, including Alzheimer’s dis-
ease (Cenini, Sultana, Memo, & Butterfield, 2008), but it is
not clear whether this is a cause or consequence of path-
ology (Szybinska & Lesniak, 2017). Knockdown of p53 in
microglia prevents Ab-induced activation and the neurotoxic
effects of microglial apoptosis (Davenport, Sevastou, Hooper,
& Pocock, 2010). Consistent with this, in our screen knock-
down of p53 in adult Drosophila neurons significantly
reduced the Ab-induced decline in motor performance
whilst having no effect on the control (Figure 3(d)).
Thus, we have shown that DART can be used as a rapid,
reproducible and sensitive motor performance assay to iden-
tify age-dependent phenotypes with the potential to be used
for large-scale screening of pharmacological or genetic modi-
fiers of neurodegeneration.
Discussion
One advantage of using Drosophila as an animal model of
neurodegenerative disorders is the disease course is much
shorter than with vertebrate models. A widely-used method
to follow the disease course in Drosophila neurodegeneration
models is to measure the age-dependent decline in motor
function that manifests in almost every case (Bouleau &
Tricoire, 2015; Casci & Pandey, 2015; Hewitt & Whitworth,
2017; McGurk et al., 2015). By far the most commonly used
assay for assessing motor function is the negative geotaxis
climbing assay, first described in the 1970s (Ganetzky &
Flanagan, 1978). However, this requires large numbers of
flies and data points and extensive hands-on experimenter
time. Solutions to automate the assay to increase throughput
or to reduce variability have generally involved bespoke
engineering and/or software (e.g. Kohlhoff et al., 2011; Liu
et al., 2015; Podratz et al., 2013; Willenbrink et al., 2016).
Here, we have presented an alternative setup which does not
rely on climbing but instead on startling the flies in horizon-
tal vials through vibration. The setup is based on the open-
source, MATLAB-based DART software package (Faville
et al., 2015) which is GUI-based and does not require cod-
ing skills to use. The apparatus is relatively inexpensive and
commercially available, avoiding the need for bespoke engin-
eering. The setup requires far fewer flies than the climbing
assay and requires only a small number of recordings (10)
to give a high power to detect differences in motor perform-
ance between groups. In addition, the software controls the
delivery of vibrational stimuli to the flies and these can be
varied in duration and intensity to suit different experimen-
tal paradigms. We have demonstrated in this study that the
DART system produces reproducible data with a well-char-
acterised Drosophila neurodegeneration model using cohorts
of 20 flies only; that it is has greater sensitivity to detect dif-
ferences between groups than the standard climbing assay;
and that it has the potential to be used in large-scale screens
for modifiers of neurodegeneration.
One of the key advantages of the DART setup over
climbing assays is the reduction of the experimenter hands-
on time. We have routinely run assays with only 20 flies per
genotype vs. 100 flies in our climbing assays. Given most
experiments require age-matched flies of multiple genotypes,
using DART results in a large reduction in fly handling at
each stage of the breeding process. Moreover, the food in
the mini-vials used in this system needs to be replaced only
on a fortnightly basis, provided that the incubator is main-
tained at 70% humidity. In our case, the duration of each
assay was 1 h, but since the vibrational stimuli are controlled
by the software, there is no need for the experimenter to be
present (unlike for the manual tapping of vials in the stand-
ard climbing assays). Furthermore, tracking of the fly posi-
tions and quantification of locomotion behaviours are
handled by the DART software, in contrast to the climbing
assay, which is routinely scored manually by the experi-
menter from video files.
A weakness of the DART setup is the day-to-day vari-
ation in the startle response of the flies. We saw variable
responses for genetically identical flies, housed identically.
The reasons for this are not clear. However, we were able to
reduce the effect of this variation by recording the startle
responses of the flies on 2–3 occasions in the period post-
eclosion but before the shift to a higher temperature i.e.
before induction of tAb1–42 expression. This provided a
baseline response for each cohort used for normalization
and generation of a PI (see “Methods”). Regression lines
were then fitted to the longitudinal data for comparison
between groups. This method produces highly reproducible
data with only 20 flies per genotype (Figure 2(a)) but does
mean the DART setup is more suitable for measuring longi-
tudinal performance, such as the age-dependent decline in
motility in neurodegeneration, rather than to compare
motility in one-off, single time point experiments. Other
metrics quantified by DART may prove useful measures in
the future, such as pre-stimulus speed, which cannot be
measured by the RING assay (Gargano et al., 2005), or sleep
duration. The shape of the response curves of cohorts of
flies may also provide information about the motor perform-
ance to accompany the amplitude of the response: we have
seen examples where two genotypes decline at a similar rate
but the flies of one cohort fail to respond coherently to the
stimulation at older ages while the controls do still respond
similarly within the group; this data manifests itself as a dif-
ference in goodness-of-fit to the exponential model DART
uses to calculate mean amplitude of response. We have also
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been able to demonstrate significant differences in this
response to vibration without accompanying changes to the
mean walking speed over the duration of the experiment
(Figure 1(c)). This would not be possible to observe in a
setup such as iFly, that calculates average velocity in
unstimulated conditions (Kohlhoff et al., 2011) or with the
Trikinetics DAM activity monitors used in a previous study
of the neuroprotective effects of curcumin on Ab toxicity
(Caesar, Jonson, Nilsson, Thor, & Hammarstr€om, 2012).
During our testing of the application of DART as a
screening tool for modifiers of the neurodegeneration
phenotype, we identified a neuroprotective effect of knock-
ing down p53 expression in neurons. p53 is known to have
a pro-apoptotic role: its overexpression leads to widespread
apoptosis in cultured hippocampal neurons (Jordan et al.,
1997). In addition, under neurodegenerative conditions, p53
increases oxidative stress by activation of pro-oxidant genes
and repression of antioxidant genes (Chatoo, Abdouh, &
Bernier, 2010). There is growing evidence for cooperation
between Ab and p53 in the progression of Alzheimer’s dis-
ease (Jazvinscak Jembrek, Slade, Hof, & Simic, 2018).
Therefore, p53 is a potential target for treating various neu-
rodegenerative disorders (Chang et al., 2012; Culmsee &
Mattson, 2005), but little work has been done in vivo. Our
results demonstrate that knockdown of p53 in neurons in
vivo reduces the decline of motor function in our tAb1–42
model, strengthening the case for future work targeting p53
in neurons to ameliorate pathology.
In conclusion, we have demonstrated a novel method for
quantifying the progression of motor performance decline in
Drosophila neurodegeneration models that is reproducible,
sensitive and rapid compared to other assays and which
reduces hands-on time considerably. We have highlighted
how it is best suited to tracking longitudinal performance
such as the age-dependent decline of motility in neurode-
generation, and how different aspects of motor performance
can be affected differently in these models. Finally, we have
shown the utility of DART as a high-throughput screen for
modifiers of neurodegeneration, with our screen providing
in vivo evidence that p53 may be an effective target for neu-
roprotection in Alzheimer’s disease.
Methods
Drosophila husbandry
Fly crosses were maintained on a standard yeast–sugar–agar
food mix (50 g/L yeast, 50 g/L glucose, 0.8% agar, 1% soy
flour). Crosses were maintained at 18 C in all cases and
shifted to 25, 27 or 29 C 1–2 days post-eclosion. Relative
humidity was kept constant at 70%.
Drosophila genetics
The driver line used in all experiments was the pan-neuronal
driver Elav-GAL4C155 combined with a tubP-GAL80ts inser-
tion on chromosome II. The temperature-sensitive GAL80
represses GAL4 activity at 18 C, allowing us to limit neur-
onal Ab expression to adulthood. The control line used was
an isogenic w1118 (BL5905). Virgin females of the driver
lines were crossed to UAS-Ab1–42 (12-linker) males (Speretta
et al., 2012), or to w1118/Y control males. Drosophila lines
were supplied by the Bloomington stock centre except for
the UAS-Ab1–42 which was a kind gift of Dr Damien
Crowther (University of Cambridge).
Climbing assays
For each genotype, flies were separated into 10 cohorts of 10
flies in vials and shifted to either 25 or 29 C after an initial
“Day 0” climbing assay. 5 empty vials were marked with a
line 3 cm from the base to be used as the climbing apparatus.
Flies were allowed 1 h to acclimatise to laboratory tempera-
ture and humidity, before being transferred into the test vials.
Climbing was tested within the same 2 h time window each
time. For testing, flies were tapped to the bottom of the vial,
and the number climbing above the line after 10 s recorded
using a Logitech C920HD webcam at 480p. The tap was
repeated twice more after a 20 s interval. Flies climbing above
the lines was determined manually from recordings. During
the analysis, results from the 2nd and 3rd taps only were used
since climbing performance was inconsistent on the first tap.
Finally, flies were returned to food-containing vials after each
experiment. The food was changed once per week.
DART movement tracking
Fly handling
1–2 days post-eclosion, male flies were collected under CO2
anaesthesia, sorted for genotype and 20 flies transferred
to individual 5 65mm Trikinetics monitor tubes
(Trikinetics.com) with a small amount of food inserted at
one end. The food end was covered with a small rubber cap
to prevent drying out and cotton wool was used to seal the
other end. Tubes were housed at constant temperature and
70% rel. humidity. Tubes were moved to the testing room
1 h before the start to acclimatise the flies and replaced in
the incubator after testing. Movement was tested within the
same 2 h time window each day.
Equipment setup
The equipment setup was essentially as described (Faville
et al., 2015) with minor modifications. Briefly, tubes were
housed on horizontal platforms supplied by BFKlabs (www.
bfklab.com) with each tube held in place by clips. The plat-
forms were immobilised on the base of a photography copy
stand with a Logitech webcam positioned above. The camera
was set to record at a resolution of 960 540 at 5 fps. Each
platform had two coin motors attached to the underside to
deliver vibrational stimuli under the control of the DART
software. The apparatus was housed in a room with constant
temperature and a stable lighting setup arranged to minim-
ise intensity variation across the apparatus and to eliminate
glare or shadows on the glass vials. An image of the setup is
included in Supplementary Figure S1. The DART software
ran under MATLAB (2017a) on a standard PC.
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Experimental paradigm
The experimental paradigm was controlled by DART. It
comprised recording for 5min to establish baseline speed of
movement followed by a 3.5 V (2.4 g) vibrational stimulus
event delivered in 5 0.5 s bursts with 0.1 s between each.
The stimulus events were repeated a further four times with
10min between events. After the final stimulus, the recording
was continued for a further 15min. The total recording time
was 1 h. The experimental paradigm, an example dataset and
diagrammatic explanation of the performance index calcula-
tion is shown in Supplementary Figure 2.
Movement tracking
Within the DART suite, each video was loaded into the Fly
Position Tracking program and each platform identified and
individual vials delineated. The background image was cal-
culated and then the position of each fly within its vial
determined at 5Hz.
Quantification of movement
The mean walking speed of the cohort was calculated within
the DART Quantification program for each tracking position
i.e. at 5Hz. Pre-stimulation speed was set as the mean speed
for the 120 s prior to delivery of the vibration. The response
of each fly within the cohort to the stimulus was aggregated
to calculate the maximum speed of the population and
hence the amplitude of the startle response for the cohort
for each of the five stimulation events. Speed calculations
were exported from DART as .csv files and processed within
Excel and Prism.
Statistics and analysis
All linear regression and statistical tests were performed in
GraphPad Prism 7.
For the climbing assays, the mean proportion of flies climb-
ing above the line in the 2nd and 3rd repeats were calculated
and tabulated in Excel as a performance index (PI), where:
PI ¼ number of flies crossing the line=total number of flies:
Flies touching the line were adjudged to have crossed it.
The PI, SD and n of each genotype for each day was trans-
ferred into an XY graph in Prism.
To calculate a PI for the DART data, the mean amplitude
of response (defined at the maximum speed post-vibration
minus the pre-stimulus speed) on the days prior to the tem-
perature shift was calculated and used as the baseline (such
that the “day 0” PI ¼ 1). All subsequent recordings were
then normalised to this baseline in Excel and then trans-
ferred into Prism (see Supplementary Figure S2).
For all experiments, linear regression lines were fit to the
PI data with the line constrained to go through the point
X¼ 0, Y¼ 1. The values of the slope, associated standard
error and N were then compared with ordinary one-way
ANOVA with Tukey’s multiple comparisons test. The com-
parison of the day 0 and day 19 PI and mean speed was
performed using two-way ANOVA with Sidak’s multiple
comparisons test.
Power calculations
All power calculations were performed in GPower. We cal-
culated the sample size required a priori based on the effect
size and standard deviation determined from preliminary
experiments. If we use DART to compare the PI of two dif-
ferent groups on any given day, a difference in PI of 0.5 can
be detected at 90% power at a¼ 0.05 with n¼ 5 stimulations
per group. Effect size in this case¼ difference/SD ¼
0.5mm s1/0.2mm s1¼2.5.
If we use DART to compare slopes of regression lines
(here n¼number of days of recording), a representative
effect size of 1.37 can be detected at 90% power at a¼ 0.05
with n¼ 10 days of recording per group (equivalent to 2–3
times per week over the course of an experiment).
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